Insider Transactions in Q4 2022 at Seagen Inc. (SGEN)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2022
|
Charles R Romp EVP, Commercial U.S. |
SELL
Open market or private sale
|
Direct |
1,129
-1.89%
|
$143,383
$127.63 P/Share
|
|
Dec 14
2022
|
Roger D Dansey President, R&D & CMO |
SELL
Open market or private sale
|
Direct |
10,000
-4.7%
|
$1,350,000
$135.0 P/Share
|
|
Dec 14
2022
|
Roger D Dansey President, R&D & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.34%
|
$750,000
$75.04 P/Share
|
|
Dec 12
2022
|
Nancy A Simonian |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+12.24%
|
$315,000
$36.7 P/Share
|
|
Nov 17
2022
|
Jean I Liu Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,333
-8.86%
|
$1,091,623
$131.05 P/Share
|
|
Nov 17
2022
|
Jean I Liu Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+8.14%
|
$283,322
$34.2 P/Share
|
|
Nov 14
2022
|
Jean I Liu Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,301
+1.5%
|
$98,876
$76.86 P/Share
|
|
Nov 11
2022
|
David W Gryska |
SELL
Open market or private sale
|
Direct |
7,500
-15.71%
|
$967,500
$129.1 P/Share
|
|
Nov 09
2022
|
Sandra M Swain |
BUY
Grant, award, or other acquisition
|
Direct |
778
+50.0%
|
-
|
|
Nov 09
2022
|
David R Epstein CEO |
BUY
Grant, award, or other acquisition
|
Direct |
107,389
+50.0%
|
-
|
|
Oct 17
2022
|
Roger D Dansey President, R&D & CMO |
SELL
Open market or private sale
|
Direct |
10,000
-3.3%
|
$1,350,000
$135.0 P/Share
|
|
Oct 17
2022
|
Roger D Dansey President, R&D & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.18%
|
$730,000
$73.14 P/Share
|